HORIZON-JU-GH-EDCTP3-2023-01-03
HORIZON-JU-GH-EDCTP3-2023-01-03
Programme: Horizon Europe
6 projects · €24,682,263 total EU contribution (project-level) · 45 participating organizations · 22 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€24,682,263
Countries active
Participant organizations by country (headquarters in CORDIS).
- UG (5)
- UK (5)
- ZA (5)
- TZ (4)
- CH (3)
- Netherlands (3)
- CD (2)
- KE (2)
- MW (2)
- SE (2)
- BE (1)
- BF (1)
- Germany (1)
- Spain (1)
- ET (1)
- ML (1)
- MZ (1)
- NG (1)
- NO (1)
- RW (1)
- SN (1)
- US (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- LSTM2 projects · UK
- THE UNIVERSITY OF LIVERPOOL2 projects · UK
- AIMS NEI1 projects · RW
- THE AGA KHAN UNIVERSITY- KENYA1 projects · KE
- ARMAUER HANSEN RESEARCH INSTITUTE1 projects · ET
- Bfly Operations, Inc1 projects · US
- CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE ET TECHNOLOGIQUE*INSTITUT DE RECHERCHE EN SCIENCES DE LA SANTE1 projects · BF
- ERASMUS MC1 projects · NL
- FARMOVS (PTY) LTD1 projects · ZA
- FM1 projects · MZ
- ISGLOBAL1 projects · ES
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1 projects · UK
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
PReparing for Optimal Phase III/IV maTErnal Group B StreptococCal vaccine Trials in Africa (PROTECT) PROTECT · 101145724 | HORIZON | €3,271,991 | €224,688 | Details |
OPTIMIZING THE IMPLEMENTATION AND SCALE-UP OF THE WHO TB TREATMENT DECISION ALGORITHMS FOR CHILDREN WITH PULMONARY TUBERCULOSIS IN SUB-SAHARAN AFRICA OPTIC-TB · 101145735 | HORIZON | €3,999,998 | €501,905 | Details |
Drug Optimisation in LMICs of Pregnant HIV women and their Infants: temporary switch to CAB/RPV long acting injections DOLPHIN-3 · 101145722 | HORIZON | €3,205,161 | €0 | Details |
Oxygen Optimization Therapy through BCPAP for management of childhood pneumonia in general hospitals of LMICs OPT-bCPAP · 101145797 | HORIZON | €4,641,691 | €849,446 | Details |
SAFETY OF ANTIMALARIALS IN THE FIRST TRIMESTER: AN ADAPTIVE PLATFORM TRIAL SAFIRE · 101145740 | HORIZON | €5,191,431 | €1,791,674 | Details |
POINT OF CARE ULTRASOUND FOR PEDIATRIC LOWER RESPIRATORY TRACT INFECTIONS IN SUB-SAHARAN AFRICA IMCI-PLUS · 101145822 | HORIZON | €4,371,990 | €932,361 | Details |